SPONSOR
Queen Mary University of London
Total Trials
6
Recruiting
6
Phases
Phase 2, Phase 3
Conditions studied: Breast Cancer RiskOvarian Cancer RiskCancer Gene MutationUrinary Bladder NeoplasmsThrombosisInjury LegCoronary Artery Disease (CAD)Stable Angina PectorisIschaemic Heart Disease (IHD)Asthma Intermittent, Uncontrolled
Queen Mary University of London is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Breast Cancer Risk, Ovarian Cancer Risk, Cancer Gene Mutation, Urinary Bladder Neoplasms.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Queen Mary University of London
How many clinical trials has Queen Mary University of London sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Queen Mary University of London, of which 6 are actively recruiting participants. These trials cover conditions including Breast Cancer Risk, Ovarian Cancer Risk, Cancer Gene Mutation. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Queen Mary University of London research focus on?
Queen Mary University of London clinical trials span Breast Cancer Risk, Ovarian Cancer Risk, Cancer Gene Mutation, Urinary Bladder Neoplasms, Thrombosis, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Queen Mary University of London clinical trial?
To participate in a Queen Mary University of London trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Queen Mary University of London trials with current recruitment status updated daily.
Clinical Trials by Queen Mary University of London
NCT07498829
Recruiting
Population Based Germline Testing for Early Detection and Prevention of Cancer
Breast Cancer Risk
NCT06892860 Phase 2
Recruiting
Comparing 3 vs 6 Cycles of Platinum-based Chemotherapy Prior to Maintenance Avelumab in Advanced Urothelial Cancer
Urinary Bladder Neoplasms
NCT06370273 Phase 3
Recruiting
Thromboprophylaxis in Lower Limb Immobilisation
Thrombosis
NCT07864025
Recruiting
Identification of Lesion Characteristics in Coronary Plaques Using Multimodality Intravascular Imaging and Novel Photon-counting CT in Stable Angina
Coronary Artery Disease (CAD)
NCT06849245
Recruiting
Εffectiveness of a Digital Social Intervention in Primary Care
Asthma Intermittent, Uncontrolled
NCT05208567
Recruiting
London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardiac Ultrasound
Heart Valve Diseases
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology